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MRI Measures of Middle Cerebral Artery Diameter in
Conscious Humans During Simulated Orthostasis
Jorge M. Serrador, MSc; Paul A. Picot, PhD; Brian K. Rutt, PhD;
J. Kevin Shoemaker, PhD; Roberta L. Bondar, MD, PhD
Background and Purpose—The relationship between middle cerebral artery (MCA) flow velocity (CFV) and cerebral
blood flow (CBF) is uncertain because of unknown vessel diameter response to physiological stimuli. The purpose of
this study was to directly examine the effect of a simulated orthostatic stress (lower body negative pressure [LBNP])
as well as increased or decreased end-tidal carbon dioxide partial pressure (PETCO2) on MCA diameter and CFV.
Methods—Twelve subjects participated in a CO2 manipulation protocol and/or an LBNP protocol. In the CO2 manipulation
protocol, subjects breathed room air (normocapnia) or 6% inspired CO2 (hypercapnia), or they hyperventilated to
'25 mm Hg PETCO2 (hypocapnia). In the LBNP protocol, subjects experienced 10 minutes each of220 and
240 mm Hg lower body suction. CFV and diameter of the MCA were measured by transcranial Doppler and MRI,
respectively, during the experimental protocols.
Results—Compared with normocapnia, hypercapnia produced increases in both PETCO2 (from 3663 to 4064 mm Hg,
P,0.05) and CFV (from 6364 to 8066 cm/s, P,0.001) but did not change MCA diameters (from 2.960.3 to
2.860.3 mm). Hypocapnia produced decreases in both PETCO2 (2462 mm Hg, P,0.005) and CFV (4367 cm/s,
P,0.001) compared with normocapnia, with no change in MCA diameters (from 2.960.3 to 2.960.4 mm). During
240 mm Hg LBNP, PETCO2 was not changed, but CFV (5564 cm/s) was reduced from baseline (5864 cm/s,P,0.05),
with no change in MCA diameter.
Conclusions—Under the conditions of this study, changes in MCA diameter were not detected. Therefore, we conclude
that relative changes in CFV were representative of changes in CBF during the physiological stimuli of moderate LBNP
or changes in PETCO2. (Stroke. 2000;31:1672-1678.)
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Ever since Aaslid et al1 introduced transcranial Doppler(TCD) as a noninvasive method of determining beat-by-
beat relative changes in cerebral flow velocity (CFV), many
groups have adopted use of this technique to examine
cerebrovascular control. The basic assumption with this
methodology is that relative changes in CFV represent
relative changes in cerebral blood flow (CBF) as long as there
is no change in arterial diameter at the point of insonation.
This assumption has been challenged,2 and several groups
have found poor correlations between changes in CFV and
CBF during drug stimulation.3–7 This may have been due to
drug-induced constriction or dilation of the middle cerebral
artery (MCA), which may result in a change in CFV without
any effect on CBF.4–7
In contrast, others have found good correlations between
relative changes in CFV and CBF by using various tech-
niques: xenon (133Xe), single-photon emission computed to-
mography (SPECT), MRI, and direct Fick calculations from
the arterial to jugular venous oxygen difference under various
stimuli.8–10
Giller et al11 directly measured MCA external diameter
during open craniotomy and found no change in the dimen-
sions of this vessel during manipulations of end-tidal CO2.
Similarly, cerebral angiography12,13 and MRI14 techniques
have not detected changes in MCA diameter under various
stimuli. However, the majority of these studies were per-
formed on anesthetized patients,11–13 in whom cerebrovascu-
lar response may have been compromised,15,16 or under a
limited range of cerebral vasomotor stimuli.14
In animals, MCA dimensions appear to be sensitive to
increased sympathetic outflow.17–19However, large interspe-
cies differences in the response of the various cerebral beds
suggest caution in drawing conclusions about human cere-
brovascular regulation from animal studies.20
The only study to examine MCA diameters in conscious
humans has been under hypocapnic conditions, in which no
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change in MCA diameter was found.14 The role of increased
arterial CO2 or sympathetic tone on the dimensions of large
cerebral arteries in conscious humans has not been reported.
Therefore, the purpose of the present study was to directly
measure MCA diameter by using MRI during changes in
end-tidal CO2 partial pressure (PETCO2) and lower body
negative pressure (LBNP). The latter was used to increase
sympathetic outflow. To accomplish this objective, “black
blood” magnetic resonance images (described in Subjects and
Methods) of the intraluminal diameter of the MCA during
hypocapnic, hypercapnic, and LBNP exposure were obtained.
We tested the hypothesis that MCA diameters were stable




Twelve subjects (7 women and 5 men), aged 20 to 29 years, gave
informed consent to undergo the Ethics Review
Board–approved protocol.
Experimental Protocols
Subjects participated in 1 or both of 2 experimental protocols. The
experimental protocols were performed on separate days. After
instrumentation, subjects remained supine for 10 minutes before data
collection. Both protocols began with a 2-minute collection of CFV
data, which was followed by the MRI scan ('5 minutes) and then by
another 2-minute collection of CFV data. This procedure was
performed at each level of CO2 and LBNP (Figure 1).
Experiment A: CO2 Manipulation
Three of the women and 3 of the men participated in this protocol.
To examine the effect of CO2 on CBF and diameter of the MCA, 3
levels of PETCO2 were maintained for 10 minutes so that CFV could
be monitored before and after the scanning period. After the subject
breathed room air (normocapnia), the inspired gas was switched to
contain 6% CO2 (hypercapnia). This is a typical clinical dose, and it
allowed us to investigate the assumption that MCA diameter is not
affected by this dose of inspired CO2. After the hypercapnic period,
the subject was asked to hyperventilate to a target PETCO2 value of
25 mm Hg (hypocapnia). The subject was provided with visual
feedback of the PETCO2 level and the effectiveness of his/her
breathing efforts.
Experiment B: LBNP
Five of the women and 3 of the men experienced the LBNP protocol.
The purpose of this experiment was to evoke baroreflex-mediated
increases in sympathetic discharge21 without modifying cerebral
perfusion pressure and thus not eliciting autoregulatory contributions
to changes in CFV and MCA diameter. The legs and pelvis were
sealed inside a wooden box connected to an adjustable vacuum
source to allow the development of negative pressure around their
lower limbs. An adjustable foot plate was provided to ensure that the
position of the subjects in the magnet would not change when
vacuum was applied. Each subject experienced 0,220, and
240 mm Hg negative pressure for 10 minutes each, allowing
measures of CFV for 2 minutes before and after a 5-minute period of
MRI scanning. PETCO2 values were not controlled.
Data Acquisition
Inside the MRI unit, the PETCO2 and respiratory rate (Normocap 200,
Datex) were measured with the use of a 8.2-m catheter tube (1-mm
ID) inserted into a sampling port in a face mask worn by the subject.
Previous work has shown that this length of tube has little effect on
the expired CO2 profile.22 Blood pressure was measured every 1 to 2
minutes by an automated blood pressure–monitoring cuff (Dinamap,
Critikon Inc) on the left arm. The respiratory and blood pressure
monitors were located outside the MRI room. An important aspect of
the present study was the close to simultaneous recordings of flow
velocity and diameters during each condition. CFV was recorded for
2 minutes before and after each MRI scan in each condition.
TCD Sonography
The CFV in the MCA was obtained with a 2-MHz pulsed flat TCD
probe located over the temporal bone. The signal was range-gated to
a depth of 45 to 60 mm to ensure insonation of the M1 segment of
the MCA according to standard techniques. After the optimum signal
was achieved, a hook-and-loop fastener (Velcro) headband with the
probe attached was secured for the duration of the test, including
MRI scans. The Doppler unit (Transpect TCD, Medasonics) was
located outside the MRI room and attached to the probe with a 10-m
cable that passed through the wave-guide port of the radiofrequency-
shielded room. This potential violation of the radiofrequency-
shielding integrity did not cause substantial artifact in the MR
images.
MRI Studies
MRI examinations were performed on all subjects in a General
Electric Signa Horizon EchoSpeed (version 5.5) 1.5-T clinical
scanner (General Electric Medical Systems). Black blood magnetic
resonance angiography was used to create a contrast between the
MCA lumen and the surrounding tissue. In this technique, transverse
slabs of tissue in the middle of the brain immediately adjacent to the
imaging plane and containing the carotid arteries and the circle of
Willis were chosen. These tissue sections, including the blood
present therein, were presaturated with use of a slab-selective 90°
radiofrequency pulse to produce a signal void from those tissues.
When that signal-nulled blood then flowed into the MCA in the
imaging plane, the blood within that lumen appeared black. Imaging
of the plane of interest was accomplished with a 2D cardiac-gated
fast spin echo pulse sequence by using a 5-mm slice thickness, a
12312-cm field of view, and a 2563256 matrix, giving 0.47-mm
square pixels. Other parameters of relevance were as follows: echo
train length, 4; repetition time, 2 cardiac cycles; and effective echo
time, 17 ms. Three oblique imaging planes were chosen to intersect
with each MCA normally and through a straight section (Figure 2).
Scanning sessions took'5 minutes, depending on the subject’s heart
rate (HR). During scanning sessions, the nonmetallic TCD probe was
unplugged to ensure that there was no interference with the MRI
images in the area of interest.
Four to 6 diameter images were obtained for each subject in each
condition. The diameter measurements for each scan were deter-
mined manually by 5 independent observers who were blinded to
subject or condition. Any images in which the vessel boundaries
were not clearly defined because of subject motion or vessel
Figure 1. Schematic representation of 2 experimental protocols.
MRI scans took '5 minutes depending on subject’s HR. TCD
collections lasted for 2 minutes before and after scan. Approxi-
mately 1 minute was provided between changing conditions for
subjects to reach steady state.
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tortuosity were excluded from analysis. Mean values for each
condition were obtained by averaging the values for each image from
the 5 observers. CBF was then calculated as the product of CFV and
vessel cross-sectional area. HR and blood pressure were monitored
throughout the scans.
Data Analysis
The analog CFV, HR, and PETCO2 signals were sampled simulta-
neously at 10 kHz per channel by use of an 8-channel digital tape
recorder (TEAC RD-111T, Teac Inc). Offline data analysis was
performed with customized data analysis software.23 The peak
velocity envelope of the TCD waveform was used to represent the
instantaneous blood flow velocity in the MCA. Beat-by-beat signals
were displayed during analysis, and any artifacts were removed.
Blood pressure data were recorded each minute throughout both
experimental trials. CBF was calculated as the product of CFV and
the vessel cross-sectional area by use of the MRI-derived diameter
measures for that condition. HR was obtained from the CFV
waveforms. An estimate of regional cerebrovascular resistance
(CVRest) in the distribution of the MCA was calculated as
CVRest5MAP/CFV, where MAP is the mean arterial pressure.
Interobserver agreement was assessed with a Kendall coefficient
of concordance (W) test, and a Friedman rank test was used to assess
whether all diameter measures were considered to have come from
the same population, regardless of observer.
The effect of PETCO2 or LBNP on CFV and diameter was assessed
by repeated-measures 2-way and 1-way ANOVA, respectively, with
a Student-Newman-Keuls test for multiple comparisons. Data are
presented as mean6SEM, and levels ofP,0.05 are considered
significant.
Results
We measured PETCO2, HR, and MAP both before and after
the MRI scanning period within each experimental phase to
determine whether steady-state conditions were maintained
during the MRI and transcranial Doppler measures. A signif-
icant tachycardia occurred during the first 2 minutes of
hypocapnia (P,0.05, Table 1). However, the variables with
the greatest impact on CFV, namely, PETCO2 and MAP, were
maintained throughout each experimental phase. During
LBNP, HR increased between the prescan and postscan
periods (P,0.05), but MAP was maintained (Table 2). In the
LBNP conditions, there were no differences between the
prescan and postscan values of CFV (Table 2); however,
there was a significant increase in CFV during the postscan
period of hypocapnia (Table 1). Together, these data indicate
that CFV and MCA diameter measures were made under
steady-state conditions.
Of the 270 images captured, 158 were considered suitable
for analysis. Strong interobserver concordance was observed
between diameter measures across all observers (Kendall
W50.74). Also, the Friedman test was significant (P,0.001),
indicating that all diameter measures were drawn from the
same population regardless of observer.
PETCO2 Manipulations
Compared with normocapnia, PETCO2 increased and de-
creased significantly during the hypercapnic and hypocapnic
conditions, respectively (P,0.05, Table 1). MFV was in-
creased by 26% and decreased by 33% during hypercapnia
and hypocapnia, respectively (P,0.001, Figure 3). CVRest
increased by 49% (P,0.05) during hypocapnia and decreased
by 13% (P,0.05) during hypercapnia. MCA diameters were
not altered from normocapnia by either hypercapnia or
hypocapnia (Figure 3). Examination of the individual re-
sponses indicated that 4 of 6 subjects showed minimal change
TABLE 1. Response to CO2 Manipulation
Gas Condition Scan HR, bpm MAP, mm Hg PETCO2, mm Hg CFV, cm/s
Normocapnic Pre 58.663.3 84.363.0 36.561.0 63.564.3
Post 59.862.4 83.663.2 36.860.5 63.163.9
Hypercapnic Pre 64.563.7 86.262.6 44.761.0* 80.266.0*
Post 68.466.0 89.963.2 45.060.9 79.766.3
Hypocapnic Pre 85.465.0* 84.962.8‡ 23.860.4* 40.161.4*
Post 62.663.7† 89.463.4 23.560.2 45.562.4†
Values are mean6SEM. Changes in HR, MAP, PETCO2, and CFV during CO2 manipulation are shown.
*P,0.001 and ‡P,0.05 vs normocapnic (combined prescan and postscan values); †P,0.05 vs prescan value.
Figure 2. Sample MRI images used to obtain MCA diameters
during 3 CO2 conditions. Bottom tracings show TCD signal just
before imaging during normocapnic (room air), hypercapnic (6%
inspired CO2), and hypocapnic (hyperventilation) conditions.




 http://ahajournals.org by on O
ctober 4, 2021
across CO2 conditions. In the other 2 subjects, the MCA
diameter was increased (0.3 mm) in one and decreased
(0.4 mm) in the other during hypocapnia, with no detectable
change during hypercapnia.
LBNP Studies
PETCO2 levels were constant during the LBNP protocol
(Table 2). Compared with supine rest conditions, HR was
increased during240 mm Hg LBNP (P,0.05, Table 2).
With 240 mm Hg LBNP, CFV decreased from 5864 to
5564 cm/s (P,0.01, Figure 4), and CVRest was slightly but
significantly increased by LBNP (Figure 4). No changes in
MCA diameter were detected during LBNP (Figure 4).
Individual subject data demonstrated no consistent change in
diameters between supine rest and LBNP.
CFV Versus CBF
Because no change in MCA diameter was observed, the
measured values for CFV and calculated CBF were highly
correlated during the manipulations of PETCO2 (r50.94,
P,0.001) and LBNP (r50.88, P,0.001). Similarly, the
relative changes (ie, percent change) in CFV and CBF were
closely related (r250.92, P,0.001) and not significantly
different from the line of identity (Figure 5).
Discussion
The validity of relative changes in TCD CFV values as
indicative of relative changes in CBF depends on whether the
cerebral vessel diameters change. The unique feature of the
present study was the ability to alternately collect CFV via
Doppler and MCA dimensions via MRI in conscious humans.
Therefore, the 2 indices of cerebrovascular control were
measured under the same conditions in temporal proximity
without pharmacological interventions. The present study
demonstrates that MCA dimensions were stable under a wide
range of PETCO2 and simulated orthostatic stress. Therefore, it
was concluded that in conscious humans, changes in CFV
provide a valid index of changes in total MCA blood flow.
Our images of MCA diameter support the earlier findings
of Giller et al,11 who directly measured the MCA during
TABLE 2. Response to LBNP Manipulation
LBNP Condition Scan HR, bpm MAP, mm Hg PETCO2, mm Hg CFV, cm/s
Baseline Pre 65.563.1 85.162.1 35.961.0 57.964.1
Post 64.763.0 83.262.0 36.161.3 57.764.4
220 mm Hg Pre 67.263.5 83.661.9 35.161.4 57.164.0
Post 69.763.2* 83.362.2 34.761.3 56.863.9
240 mm Hg Pre 72.764.0† 82.061.8 35.060.9 55.263.8†
Post 75.063.8* 83.262.2 33.861.3 55.163.7
Values are mean6SEM. Changes in HR, MAP, PETCO2, and CFV during LBNP manipulation are shown.
*P,0.05 vs prescan value; †P,0.05 vs baseline (combined prescan and postscan values).
Figure 3. MCA CFV and diameter changes as well as values for
CVRest during normocapnic (Normo, room air), hypercapnic
(Hyper, 6% inspired CO2), and hypocapnic (Hypo, hyperventila-
tion) conditions. Values are mean1SEM. ‡P,0.001 vs Normo.
Figure 4. MCA CFV and diameter changes as well as values for
CVRest during various levels of LBNP. Values are mean1SEM.
*P,0.05 vs baseline (base).
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craniotomy. Several additional studies have failed to detect
the effects of PETCO2 on MCA dimensions by use of angiog-
raphy.12,13 Therefore, the bulk of evidence suggests that
changes in cerebrovascular resistance caused by changes in
arterial CO2 occur downstream from the MCA M1 seg-
ment.16,24 In contrast, Valdueza et al25 reported a dilation of
the MCA with hypercapnia in conscious humans. This
observation was made by comparing the change in MCA
inflow velocity with the contralateral sphenoparietal sinus
outflow velocity. However, it is not known whether differ-
ential drainage from other cerebral vascular beds and/or
whether venous sinus volumes remained constant in their
study.25
There is controversy regarding sympathetic vasoconstrictor
effects on cerebral vasculature. Sympathetic innervation of
cerebral arteries has been found to be greatest in the basal
arteries (ie, MCA and anterior cerebral artery).17 In rabbits
and cats, sympathetic activation caused increased cerebral
vascular resistance in the large cerebral arteries.26 To examine
autonomic cerebrovascular control in humans, investigators
have used models that ablate or augment sympathetic activity.
Increases in ipsilateral MCA flow velocity have been ob-
served after stellate ganglion blockade,27 suggesting tonic
sympathetic tone in MCA vessels at rest. However, sympa-
thetic blockade did not alter vertebral artery flow or diame-
ter.28 Stimulation of T2 and T3 sympathetic ganglia during
surgery caused marked increases in CFV,29 which could have
been due to vasoconstriction at the vessel of insonation or
increases in CBF. Concurrent increases in MAP during
stimulation may have augmented CBF through vessels with
impaired autoregulation secondary to anesthetic effects on
cerebrovascular control,30,31 resulting in increased CBF and
CFV. Direct infusions of norepinephrine in both anesthe-
tized32 and conscious33 patients have not affected CFV, but
cerebral vascular resistance was increased, possibly because
of the myogenic constriction after the increase in systemic
MAP.
In conscious humans, sympathetic activation during exer-
cise increased CFV,34,35 whereas cold pressor tests both
increased36,37 and decreased38 CFV. Postexercise muscle
ischemia did not change CFV.34 It is difficult to interpret
these results because MAP and sympathetic outflow increase
concurrently. Thus, there may have been a baroreflex-
mediated attenuation of sympathetic outflow.
To examine sympathetic effects on CFV without concur-
rent changes in MAP, we examined MCA diameters during
LBNP, which has been used as a stimulus for baroreflex-
mediated increases in peripheral sympathetic outflow.21
Lambert et al39 demonstrated that increased spillover of
norepinephrine from subcortical brain regions in healthy
humans at rest was correlated with increased muscle sympa-
thetic nerve activity, suggesting that cerebral and peripheral
sympathetic activity increase similarly. In the present study, a
5% decrease in CFV was observed during240 mm Hg
LBNP, with no change in MAP. This reduction in CFV was
less than the 15% to 22% reduction observed previously40 but
similar to the'4% decrease in nonfainters at240 mm Hg.41
The difference in values was likely due to different protocols
with varying levels of LBNP and time of exposure in the
different studies. Regardless, in the present study, this level of
sympathetic stimulation that resulted in a small increase in
cerebral vascular resistance did not alter the MCA diameters,
suggesting that in humans, sympathetic effects on cerebro-
vascular control occur in vessels downstream from the MCA.
Accuracy of MRI
Our values of 2.5160.20 mm for the women and
2.5460.25 mm for the men are similar to the reported
diameters from angiography of 3.0560.39 mm for women
and 3.3560.43 mm for men.42 Our smaller values are in
agreement with the finding that black blood images may
underestimate the intraluminal diameters by a mean of
0.6 mm compared with conventional angiography in the
aorta.43 Magnetic resonance angiography has proven effective
in detecting stenosis,44,45 with black blood imaging allowing
for improved imaging of both vessel walls46,47 and complex
geometry.48
Although it is still unclear what the resolution of this
imaging technique is, we believe that the resolution for the
present study was greater than the single pixel size of
0.47 mm because of the interlacing of images. With this black
blood technique, inaccuracy in diameter measurements could
be accentuated by laminar flow and flow-related enhance-
ment, pulsatility, and interobserver error. Although these
factors may have affected the response of any single case, our
data analysis approach served to reduce this variation. First, 5
independent measures of each image were determined and
found not to be statistically different from each other.
Furthermore, averaging of these multiple measures for each
subject under each condition reduced the random error by a
factor of=n. Second, we observed a very strong correlation
between each subject’s percent CFV and the corresponding
percent CBF calculated from each individual’s diameter and
CFV value for each condition (see Figure 5). If individual
diameter changes were large or inconsistent, then the corre-
lation between CFV and CBF would be expected to be less
Figure 5. Comparison of relative changes in CFV and CBF from
baseline during both experiments. Regression lines for CO2
manipulation and LBNP were not significantly different from line
of identity. Value of r2 displayed is for all data in combination.
Values are 1-minute mean6SD.
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than that observed. The use of these analysis methods should
have improved our ability to detect significant changes in
MCA diameter.
Furthermore, if we assume that the changes in MFV were
due solely to diameter changes and thus flow stayed constant,
a dilation of 0.17 to 0.64 mm would have been necessary
across subjects to account for the decrease in MFV of 32%
during hypocapnia in the present study. Similarly, the MCA
would have had to constrict by 0.41 to 0.64 mm across
subjects to account for the increase in MFV during hyper-
capnia if total MCA flow had been maintained. Changes in
MCA diameter on this order of magnitude should have been
detectable, had they occurred.
Summary
The present data support the concept that in humans, moder-
ate increases in sympathetic outflow by baroreflex disengage-
ment or chemoreflex activation do not alter MCA diameter.
With the lack of change in MCA diameter, changes in CFV
closely follow changes in CBF. Thus, these data suggest that
in conscious healthy humans, relative changes in CFV are a
good reflection of changes in CBF. However, the effects of
greater sympathetic activation or disease states on the veloc-
ity/flow relationship requires further study.
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